Breaking Alzheimer’s chronicles Dr. Dayan Goodenowe’s personal and scientific journey in the realm of neurological disease biochemistry. For a decade and a half, he honed his expertise in this domain until an unexpected breakthrough occurred: he identified low plasmalogen levels as a key contributor to Alzheimer’s. Remarkably, plasmalogens, prior to this discovery, were unknown entities to Dr. Goodenowe, having never been covered in his academic pursuits.

Today, with 15 years of robust validation supporting his findings, plasmalogen testing and supplementation has become accessible to all. Driven by unwavering determination, Dr. Goodenowe has ensured that the significance of plasmalogens in the Alzheimer’s narrative remains irrevocable. This book serves as a compass, orienting readers on the current state of this groundbreaking journey and charting the path forward.